LINDEN ADVISORS LP - NEVRO CORP ownership

NEVRO CORP's ticker is and the CUSIP is 64157FAC7. A total of 13 filers reported holding NEVRO CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
LINDEN ADVISORS LP ownership history of NEVRO CORP
ValueSharesWeighting
Q3 2023$19,993,448
+1.1%
21,366,0000.0%0.20%
-1.4%
Q2 2023$19,770,189
-1.1%
21,366,0000.0%0.21%
-1.4%
Q1 2023$19,996,138
-36.2%
21,366,000
-23.6%
0.21%
+9.9%
Q4 2021$31,351,000
-17.0%
27,962,0000.0%0.19%
-13.5%
Q3 2021$37,778,000
+175.3%
27,962,000
+254.3%
0.22%
+208.3%
Q2 2021$13,721,000
+13.2%
7,893,0000.0%0.07%
-20.0%
Q1 2021$12,124,000
+89.4%
7,893,000
+125.5%
0.09%
+87.5%
Q4 2020$6,401,000
+17.5%
3,500,0000.0%0.05%
-27.3%
Q3 2020$5,448,000
+14.2%
3,500,0000.0%0.07%
-14.3%
Q2 2020$4,770,0003,500,0000.08%
Other shareholders
NEVRO CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Perceptive Advisors 9,000,000$135,324,0001.71%
DeepCurrents Investment Group LLC 21,930,000$33,750,0001.16%
WOLVERINE ASSET MANAGEMENT LLC 44,534,000$69,564,0000.59%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 12,000,000$18,208,0000.38%
Context Capital Management, LLC 2,000$3,084,0000.30%
ZAZOVE ASSOCIATES LLC 1,500,000$2,276,0000.27%
Polar Asset Management Partners Inc. 17,500,000$26,683,0000.26%
CSS LLC/IL 2,500,000$3,780,0000.16%
Verition Fund Management LLC 7,486,000$11,543,0000.13%
PFM Health Sciences, LP 2,000,000$3,032,0000.09%
View complete list of NEVRO CORP shareholders